Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin

American Journal of Hypertension

Volumn 9, Issue 1, 1996, Pages 24-32

  Bigazzi, Roberto ^a   Bianchi, Stefano ^a   Baldari, Giorgio ^a   Campese, Vito M ^b,c  

^a UO di Nefrologia   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c LAC USC MEDICAL CENTER   (United States)

Author keywords

Hypertension; Insulin; Lipoproteins; Salt sensitivity; Urinary albumin excretion

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM CHLORIDE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SALT INTAKE;

EID: 0030046260     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00268-5     Document Type: Article

References (74)

1. Kawasaki, T, Delea, CS, Bartter, FC, Smith, H: The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978;64:193-198.
2. Dustan HP, Valdes G, Bravo EL, Tarazi RC: Excessive sodium retention as a characteristic of salt-sensitive hypertension. Am J Med Sci 1986;29:67-74.
3. Weinberger MH, Miller JZ, Luft FC, et al: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8:II127-II134.
4. Campese VM, Romoff M, Levitan D, et al: Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982;21:371-378.
5. Sullivan JM, Ratts TE: Sodium sensitivity in human subjects. Hemodynamic and hormonal correlates. Hypertension 1988;11:717-723.
6. Takeshita A, Imaizumi T, Ashihara T, Nakamura M: Characteristics of responses to salt loading and deprivation in hypertensive subjects. Circ Res 1982;51:457-464.
7. Williams GH, Hollenberg NK: "Sodium-sensitive" essential hypertension. Emerging insights into pathogenesis and therapeutic implications. Contemporary Nephrol 1985;3:303-331.
8. Campese VM: Effect of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension. Am J Cardiol 1988;62:85G-91G.
9. Campese VM, Parise M, Karubian F, Biagazzi R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991;18:805-812.
10. Fujita T, Henry WL, Bartter FC, et al: Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med 1980;69:334-344.
11. Skrabal F, Herholz H, Neumayr M, et al: Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension 1984;6:152-158.
12. Koolen MI, van Brummelen P: Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension 1984;6:820-825.
13. Gill JR, Gullner HG, Lake CR, et al: Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988;11:312-319.
14. Levy SB, Lilley JJ, Frigon RP, Stone RA: Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 1977;60:129-138.
15. Zinner SH, Margolius HS, Rosner B, et al: Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. J Epidemiol 1976;104:124-132.
16. Holland OB, Chud JM, Braunstein H: Urinary kallikrein excretion in essential and mineralocorticoid hypertension. J Clin Invest 1980;65:347-356.
17. Bigazzi R, Bianchi S, Baldari D, et al: Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 1994;23:195-199.
18. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD: Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 1988;78: 951-956.
19. Heimann JC, Drumond S, Alves ATR, et al: Left ventricular hypertrophy is more marked in salt-sensitive than in salt-resistant hypertensive patients. J Cardiovasc Pharm 1991;17(Suppl 2):S122-S124.
20. Campese VM: Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 1994;23: 531-550.
21. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistence in essential hypertension. N Eng J Med 1987; 317:350-357.
22. Swislocki AL, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989;2:419-423.
23. Berglund G, Larsson B, Anderson O, et al: Body composition and glucose metabolism in hypertensive middle-aged male. Acta Med Scand 1976;200:163-169.
24. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose torerance. N Engl J Med 1989;320:702-706.
25. Fuller JH, Shipley MJ, Rose G, et al: Coronary heart disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;i:1373-1376.
26. Pyorala K, Uusitupa M, Laakso M, et al: Macrovascular complications in relation to hyperinsulinemia in non insulin dependent diabetes mellitus. Diabete Metab 1987;13:345-349.
27. Welbon TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154-160.
28. Eschwege E, Richard JL, Thibault N, et al: Coronary heart disease plasma insulin levels: the Paris prospective study, ten years later. Horm Metab Res 1985;15(suppl):41-46.
29. Ducimetiere P, Eschwege R, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980;19:205-210.
30. Stern MP, Haffner SM: Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986;6:123-130.
31. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Int Med 1993;153:154-183.
32. White WB, Pickering TG, Morganroth J, et al: A multi-center evaluation of the A and D TM-2420 ambulatory blood pressure recorder. Am J Hypertens 1991;4:890-896.
33. Clark S, Fowlie S, Coats A, et al: Ambulatory blood pressure monitoring: validation of the accuracy and reliability of the TM 2420 according to the AAMI recommendations. J Hum Hypertens 1991;5:77-82.
34. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
35. Watt GF, Bennett JE, Rowe DJ, et al: Assessment of immunochemical methods for determining low concentration of albumin in urine. Clin Chem 1986;32: 1544-1548.
36. Silver A, Dawnay A, Landon J, Catteli WR: Immunoassays for low concentrations of albumin in urine. Clin Chem 1986;32:1303-1306.
37. SAS Institute: SAS/STAT User's Guide, Release 6.03 Edition. Cary, NC, SAS Institute, 1988.
38. Allison DB, Paultre F, Maggio C, et al: The use of areas under curves in diabetes research. Diabetes Care 1995; 18:245-250.
39. Hollenbeck CB, Chen N, Chen Y-Di, Reaven GM: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984;33:460-463.
40. Bianchi S, Bigazzi R, Valtriani C, et al: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994;23(part 1): 681-687.
41. Savage PJ, Saad MF: Insulin and atherosclerosis: villain, accomplice, or innocent bystander? Br Heart J 1993;69: 473-475.
42. Nizet A, Lefebvre P, Crabbe J: Control by insulin of sodium, potassium, and water excretion by the isolated dog kidney. Pflügers Arch 1971;323:11-20.
43. DeFronzo RA, Cooke CR, Andres R, Faloona GR, David PJ: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845-855.
44. De Fronzo RA, Goldberg M, Agus ZS: The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976;58:85-90.
45. Landsberg L, Young JB: Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 1985;9: 63-68.
46. Christensen NJ, Gundersen HJG, Hegedus L, et al: Acute effects of insulin on plasma noradrenaline and the cardiovascular system. Metabolism 1980;29:1138-1145.
47. Rowe JW, Young JB, Minaker KL, et al: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981;30:219-225.
48. Sauter A, Goldstein M, Ueta K: Effect of insulin on central catecholamines. Brain Res 1983;260:330-333.
49. Liang CS, Doherty JU, Faillace R, et al: Insulin infusion in conscious dogs - effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 1982;69:1321-1336.
50. Draznin B, Kao M, Sussman KE: Insulin and glyburide increase cytosolic free-Ca2+ concentration in isolated rat adipocytes. Diabetes 1987;36:174-178.
51. Barbagallo M, Gupta RK, Resnick LM: Independent effects of hyperinsulinemia and hyperglycemia on intracellular sodium in normal human red cells. Am J Hypertens 1990;6:264-267.
52. Stout RW, Bierman EL, Ross R: Effects of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975;36:319-327.
53. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE: Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991;260:R764-R768.
54. Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt DA, Gaillard CA: Chronic hyperinsulinemia and blood pressure. Interaction with catecholamines? Hypertension 1990;15:519-527.
55. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988;37:303-305.
56. Buchanan TA, Young JH, Campese VM, Sipos GF: Enhanced glucose tolerance in spontaneously hypertensive rats: pancreatic β-cell hyperfunction with normal insulin sensitivity. Diabetes 1992;41:872-878.
57. Buchanan TA, Sipos GF, Madrilejo N, et al: Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol 1992;262:E14-E19.
58. Sharma AM, Ruland K, Spies KP, Distler A: Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 1991;9:329-335.
59. Falkner B, Hulman S, Kushner H: Hyperinsulinemia and blood pressure sensitivity to sodium in young blacks. J Am Soc Nephrol 1992;3:940-946.
60. Voors AW, Radhkrishnamurthy B, Srinivasan SR, et al: Plasma glucose level related to blood pressure in 272 children, ages 7-15 years, sampled from a total biracial population. Am J Epidemiol 1981;113:347-356.
61. Rocchini AP, Key J, Bondie D, et al: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989;321:580-585.
62. Egan BM, Stepniakowski K, Nazzaro P: Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects. Hypertension 1994;23(suppl I):I1-17.
63. Lind L, Lithell H, Gustafsson IB, et al: Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects. Am J Hypertens 1992;5:502-505.
64. Saad MF, Lillioja S, Nyomba B, et al: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991;324:733-739.
65. Hollenbeck CB, Chen N, Chen Y-DI, Reaven GM: Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984;33:460-463.
66. Laakso M: How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-965.
67. Julius S, Gudbrandsson T: Early association of sympathetic overactivity, hypertension, insulin resistance, and coronary risk. J Cardiovasc Pharmacol 1992; 20(suppl 8):S40-S48.
68. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993;21:618-623.
69. Romoff MS, Keusch G, Campese VM, et al: Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab 1978;48:26-31.
70. + intake in normal man. Hypertension 1979;1:261-266.
71. Nishio I, Shima H, Tsuda K, et al: Relationship between the sympathetic nervous system and sodium potassium adenosine triphosphatase inhibitor in salt-sensitive patients with essential hypertension. J Hypertens 1988;6(suppl 4):S216-S218.
72. Falkner B, Onesti G, Angelakos E: Effect of salt loading on the cardiovascular response to stress in adolescents. Hypertension 1981;3(suppl II):II-195-II199.
73. Koolen MI, den Boer EB-V, van Brummelen P: Clinical, biochemical, and hemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens 1983;1(suppl 2):S21-S23.
74. Lawton WJ, Sinkey CA, Fitz AE, Mark AL: Dietary salt produces abnormal renal vasoconstrictor responses to upright posture in borderline hypertensive subjects. Hypertension 1988;11:529-536.